@article {705121,
	title = {Update on ocular cicatricial pemphigoid and emerging treatments.},
	journal = {Surv Ophthalmol},
	volume = {61},
	number = {3},
	year = {2016},
	month = {2016 May-Jun},
	pages = {314-7},
	abstract = {Mucous membrane pemphigoid is a systemic disorder that primarily affects mucous membranes. When localized to the conjunctiva, it is known as ocular cicatricial pemphigoid, a potentially blinding disease. Ocular cicatricial pemphigoid is an indication for systemic immunosuppressive treatment to achieve adequate remission. Immunosuppressive agents are selected with a "stepladder" approach, commencing with medications having the fewest side effects. We provide an update of the literature on immunomodulatory agents since 2011 as additional treatment modalities have been explored in the last 4 years.},
	issn = {1879-3304},
	doi = {10.1016/j.survophthal.2015.12.007},
	author = {Queisi, Munther M and Zein, Mike and Lamba, Neerav and Meese, Halea and Foster, Charles Stephen}
}
